Thousand Oaks, CA · Founded 2018 · Privately Held (backing)
Operator of a biotechnology company intended to develop novel and non-opioid therapies for chronic pain. Latigo Bio is based in Thousand Oaks, CA and was founded in 2018. Its last reported valuation was $530 million in Mar 2025. It has raised $304 million.
Last reported valuation
$530.0M
Oct 2026
Priced at
—
Total raised
$304.0M
Last round
—
Cap table — not yet on record
Latigo Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Latigo Bio with a free account
·The complete investor list: 14 names
·Watch Latigo Bio: the Monday email on marks, rounds and moves
